About TibaRay
The Team That Will Deliver Cures
Breakthrough technology requires more than innovation—it requires people who know how to bring it into the world. TibaRay brings together world-leading expertise across accelerator science, medicine, engineering, and commercialization to transform how cancer is treated globally.
OUR PURPOSE
Bringing the Hope of Cure to Patients Worldwide
TibaRay was founded with a singular purpose: to bring the hope of cure to patients with cancer around the world. We believe curative cancer treatment must be faster, safer, and accessible far beyond today’s largest academic centers.
Our work is driven by the conviction that meaningful clinical impact requires both scientific breakthroughs and the ability to scale them responsibly into real-world systems.
OUR VALUES
What Guides Our Work
Bold Invention
We challenge legacy designs and rethink foundational systems to unlock entirely new capabilities.
Clinical Impact
Every technical decision is grounded in improving patient outcomes and enabling future curative therapies.
Global Accessibility
We design for scale—reducing cost, complexity, and infrastructure barriers to expand access worldwide.
Execution for Real-World Success
Innovation matters only if it can be manufactured, deployed, and sustained in practice.
ADVISORS & BOARD
Global Thought Leaders in Science and Medicine
Leadership
Thinh Tran
Chief Executive Officer | Board Member
Bill Loo, MD, PhD
Chief Medical Advisor | Founder | Board Member
Sami Tantawi, PhD
Founder | Board Member
Rebecca Fahrig, PhD
Founder
Peter Maxim, PhD
Founder | Board Member
Laird Q. Cagan
Board Member
James Vetter, MD
Board Member
Amy Shiroma
Director of Operations to Leadership
Mentors & Advisors
William Wraith III
Serial Entrepreneur, Philanthropist
Jeff AmackerMBA, CFA
Radiotherapy Industry Veteran and Executive, Past CEO of TibaRay
Scott Ashworth
Head of Commercial Strategy
Alex Chin, MD, MBA
Clinical Assistant Professor, Radiation Oncology, Stanford Healthcare
Dave Boscacci
Strategic Marketing Leader & Business Innovator
Karl Otto, PhD
Chief Science Officer of Radformation, Radiotherapy and Medical Physics Technology Innovator
John Thompson
Board Advisor, Executive Recruiter
Gordon Saul, MBA
Executive Director, Stanford Byers Center for Biodesign
Magdalena Bazalova-Carter, PhD
JOIN US
Building the Future of Cancer Care Takes the Right Team
We welcome conversations with investors, partners, and collaborators who share our commitment to transforming cancer treatment through science, execution, and global impact.